Article info

PDF
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
  1. Correspondence to:
    Dr S H Polmar
    Therapeutic Area Immunology, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA; spolmar{at}rdg.boehringer-ingelheim.com
View Full Text

Citation

Díaz-González F, Alten RHE, Bensen WG, et al
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis

Publication history

  • Accepted December 2, 2006
  • First published December 14, 2006.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.